Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Quotient Limited QTNTQ

Healthcare Medical Devices

Recent & Breaking News (OTCPK:QTNTQ)

Quotient Limited to Participate in the Jefferies Virtual Healthcare Conference

GlobeNewswire May 26, 2020

Quotient Limited to Report Fiscal Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call

GlobeNewswire May 26, 2020

Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK

GlobeNewswire May 11, 2020

Quotient Limited Announces CE Mark for its SARS-CoV-2 (COVID-19) Antibody Microarray

GlobeNewswire May 1, 2020

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Final Performance Data

GlobeNewswire April 27, 2020

Quotient Limited Announces SARS-CoV-2 (COVID-19) Antibody Test Performance Update

GlobeNewswire April 21, 2020

Quotient Limited Announces the Completion of the SARS-CoV-2 Antibody Test Development

GlobeNewswire April 6, 2020

Quotient Limited to Host Investor Information Conference Call and Live Webcast

GlobeNewswire March 13, 2020

Quotient Limited Reports Concordance Data from Extended Serological Disease Screening Benchmark Study

GlobeNewswire February 24, 2020

Quotient Limited Announces CE Mark Approval for Initial Serological Disease Screening Microarray

GlobeNewswire February 14, 2020

Quotient Limited Provides an Update on Recent MosaiQ Milestone Achievements together with Third Quarter Fiscal 2020 Results

GlobeNewswire January 30, 2020

Quotient Limited to Report Third Quarter 2020 Financial Results and Host Conference Call

GlobeNewswire January 21, 2020

Quotient Limited Provides an Update on Recent Milestone Achievements for its MosaiQ Multimodality Multiplexing Diagnostic Platform

GlobeNewswire January 10, 2020

Quotient Announces Equity Awards

GlobeNewswire January 8, 2020

Quotient Announces Appointment of New Chief Financial Officer Peter Buhler and Chief Operating Officer Ed Farrell

GlobeNewswire January 7, 2020

Quotient Limited Reports Concordance Data from MDS Concept Study

GlobeNewswire December 5, 2019

Quotient Limited to Participate in the Jefferies 2019 London Healthcare Conference

GlobeNewswire November 18, 2019

Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares

GlobeNewswire November 12, 2019

Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares

GlobeNewswire November 6, 2019

Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares

GlobeNewswire November 6, 2019